Research News

Research News - August 14, 2015

August 14, 2015

ANNOUNCEMENTS

1. PEAS Enrollment Required for all Apple Macintosh Products
2. Innovation Service Survey
3. Core of the Week: PET Core

EVENTS

1. MGH/Harvard Cutaneous Biology Research Center Seminar Series
2. Invitation to submit abstracts for MGH Clinical Research Day

FUNDING OPPORTUNITIES

1. Call for Pre-Proposals - Sanofi iAwards Program
2. Pilot funding: Up to $50,000 for Proposals in Schizophrenia or Human Oral Microbiome
3. Private Funding Opportunities
4. Limited Submission Funding Opportunities
5. NIH Update for Week Ending August 14, 2015

In Case You Missed It

Reminders of recently posted funding opportunities, deadlines and events

ANNOUNCEMENTS

1. PEAS Enrollment Required for all Apple Macintosh Products

The IT Asset Management Standards for Apple Macintosh Products (EISS- 8.1d) are effective as of August 1, 2015. The standards require all institutionally owned or issued Macintosh devices be enrolled in the Partners Enterprise Apple Support (PEAS) program. Individuals have 90 days from August 1, 2015 to comply with the new standard. Click here to read more.

2. Innovation Service Survey

Please take the Partners HealthCare Innovation 2nd Annual Service Survey. This annual survey will help us provide the highest quality service to our constituents. Action plans and priorities will be set based on survey results. The survey is open until Friday, October 3, 2015.

To begin, please click here: https://www.surveymonkey.com/s/5VLB9K5. If you have any questions or concerns regarding this survey, please contact innovations@partners.org.

3. Core of the Week: PET Core

PET Core
Director: Georges El Fakhri, PhD
Location: Blossom St., Edwards Basement and White II, Boston

The PET Core Laboratory provides a full range of technical and professional services for the design and execution of programs using Positron Emission Tomography (PET).

The PET Core Facility provides the required facilities and personnel on a per study basis to allow investigators to use PET without requiring them to acquire the needed special expertise and equipment.

To learn more about the PET Core, please click here.

EVENTS

1. MGH/Harvard Cutaneous Biology Research Center Seminar Series

Monday, August 17, 2015, 4:00pm, CNY Bldg 149 – East, Isselbacher Auditorium, 7th Floor

“Chemistry and Biology of Oxidatively Induced DNA Lesions”
Yinsheng Wang, PhD
Professor of Chemistry, Director, Environmental Graduate Program
Department of Chemistry, University of California Riverside

Contact: vtheodoracopoulos@partners.org

2. Invitation to submit abstracts for MGH Clinical Research Day

Thursday, October 8, 8:00am - 12:00pm, O’Keeffe Auditorium & Bulfinch Tents

On Thursday, October 8, MGH will celebrate the 13th Annual Clinical Research Day. The Division of Clinical Research invites investigators from across the hospital to submit abstracts at https://crp2015.abstractcentral.com/ by the September 8th deadline.

Please note that submissions must be about clinical research conducted at MGH and may include manuscripts published after September 1, 2014.

MGH awards for best abstracts:

$5,000 Team Award (Nominations by chiefs required)
$1,500 Translational Research Award, sponsored by the Department of Molecular Biology
$1,000 Individual Award
Departmental Awards for clinical researchers in Anesthesia, Dermatology, Emergency Medicine, Medicine, Neurology, Ob/Gyn, Pathology, Pediatrics, Pediatric Surgery, Performance Analysis and Improvement/Practice Improvement, Psychiatry, Radiology, Surgery
A raffle sponsored by Mass General Research Institute

Clinical Research Day will begin at 8 a.m. with the keynote address delivered by Dr. Mark Fishman, President, Novartis Institutes for BioMedical Research.

Please contact Jillian Tonelli with any questions.

FUNDING OPPORTUNITIES

1. Call for Pre-Proposals - Sanofi iAwards Program

1. Call for Pre-Proposals - Sanofi iAwards Program

The Sanofi iAwards program brings together 7 top academic research institutions across the country and aims to support research ideas early in the translational path, at the transition between basic research and first proof of concept. Annual funding for each award granted by Sanofi will be ca. $100k total cost representing $57.5k direct cost and may be extended for one additional year at a similar funding level. Successful projects have the potential to grow into sponsored research agreements with significantly increased funding levels and timelines.

The Sanofi iAwards Program is expected to fund 24 projects per year for 3 years across the 7 participating academic entities: John Hopkins University, University of Pennsylvania, Cornell University Medical Center, Columbia University, Brigham and Women`s Hospital, Massachusetts General Hospital and University of Texas System. It will be subject to the oversight of a Joint Scientific Steering Committee (JSSC) comprised of 2 to 6 representatives from Sanofi and 1 representative from each of the academic institutions participating in the iAward Program. Our representative will be Maurizio Fava, MD, MGH Research Institute, Clinical Research Division Director. Each JSSC member will sign a confidentiality acknowledgement. The notification of pre-proposals chosen to be pursued as detailed proposals will be done by Sanofi. The JSSC will review the invited detailed proposals and make recommendations for funding by Sanofi.

The conditions related to program's governance and management, intellectual property, confidentiality have been negotiated and agreed by all Parties.

For additional information and all questions please contact our Coordinating Team: Gabriela Apiou, PhD, MGH Research Institute, Director for Translational Research Training and Development (gapiou@mgh.harvard.edu) and Seema Basu, PhD, Partners HealthCare Innovation, Director for Licensing and Strategic Collaborations (ssbasu@partners.org).

Please send pre-proposals by email to both Gabriela Apiou and Seema Basu by September 4, 2015. This will allow the Partners HealthCare Innovation Office to complete the uploading process and meet the Sanofi deadline (September 10, 2015). Please limit the total length of your pre-proposal to a maximum of 3 pages. This does not include the cover page or biographical sketch. All information in the pre-proposal should be non-confidential.

Please click here to view the call. To download the template, click here.

2. Pilot funding: Up to $50,000 for Proposals in Schizophrenia or Human Oral Microbiome

ReSourcing Big Data Pilot Funding Opportunities
As a follow-up to the successful ReSourcing Big Data Symposium held in March, up to $50,000 is available for translational research projects in two areas: schizophrenia or the human oral microbiome.

To learn more and apply, you must attend an educational event on September 16.

Human Oral Microbiome: Collaboration Opportunity
12:30-2:00pm, Countway Library, HMS
Open Translational Science Schizophrenia
4:00-5:30pm, Countway Library, HMS

Proposal applications due mid-October; more information on these opportunities can be found below and on the website.

For more information on either of these opportunities or the education events, please contact us.

3. Private Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

Stipends (Scholarships), Fritz Thyssen Stiftung/Fritz Thyssen Foundation

Please click here for further details on these funding opportunities.

4. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org. In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

Name of the Principal Investigator with appropriate contact information
A descriptive title of the potential application
Brief description of the project
Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

Claude D. Pepper Older Americans Independence Centers (P30)
Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)
Nanomaterials Health Implications Research (NHIR): Comprehensive Evaluation of Interactions between Engineered Nanomaterials and Biological System (U01)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

5. NIH Update for Week Ending August 14, 2015

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm